Internal Medicine, Hematology & Oncology · Mayaguez, PR
NPI
1356659510
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Mayaguez Medical Emporium II, Suite A-15
Mayaguez, PR, 00680
Phone (787) 831-6429
Groups this clinician bills Medicare through
Medicare paid, 2024
$255K
18,690 services
Medicare patients, 2024
16
Average age 74
Drug cost, 2024
$3.4M
1,078 prescriptions
Company payments, 2025
$9,967
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maryangely E Moreno Campa was code 99213 (office e&m - established), 33 times for 12 patients. In total Maryangely E Moreno Campa billed 18,690 services in 31 codes, and Medicare paid $255K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 33 | 12 | $64.63 | $2,133 |
By year: 2022 $179K for 13,699 services; 2024 $255K for 18,690 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maryangely E Moreno Campa prescribed most often to Medicare patients was Anastrozole, with 213 prescriptions and refills. In total Maryangely E Moreno Campa wrote 1,078 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 213 | 243 | 39 | $3,148 |
| Ondansetron Hcl Generic | 82 | 82 | 43 | $976 |
| Famotidine Generic | 73 | 82 | 34 | $374 |
| Exemestane Generic | 60 | 70 | 11 | $4,323 |
| Xtandi Enzalutamide | 45 | 45 | Under 11 | $639K |
| Erleada Apalutamide | 44 | 46 | Under 11 | $495K |
| Hydroxyurea Generic | 42 | 42 | 12 | $1,572 |
| Prednisone Generic | 38 | 38 | 18 | $231 |
| Ibrance Palbociclib | 36 | 36 | Under 11 | $584K |
| Erivedge Vismodegib | 28 | 28 | Under 11 | $368K |
| Abiraterone Acetate Generic | 20 | 20 | Under 11 | $28K |
| Prolia Denosumab | 20 | 120 | 12 | $35K |
| Revlimid Lenalidomide | 19 | 19 | Under 11 | $423K |
| Synthroid Levothyroxine Sodium | 18 | 18 | Under 11 | $886 |
| Alendronate Sodium Generic | 17 | 19 | Under 11 | $92.17 |
Brand drugs: 308 claims; generic drugs: 770 claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maryangely E Moreno Campa $9,967 ($9,967 in general payments such as food, travel and fees) from 23 companies. The largest payer was Merck Sharp & Dohme LLC with $7,157.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 19 | $7,157 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $335 |
| Janssen Pharmaceuticals, Inc JNJ | 15 | $325 |
| Pbg Puerto Rico LLC | 15 | $316 |
| Abbvie Inc. ABBV | 16 | $314 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $296 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $176 |
| Bayer Puerto Rico Inc. BAYN.DE | 5 | $139 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $138 |
| Incyte Corporation INCY | 6 | $136 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.